Hepatitis B and measles seroprevalence among Turkish children

Turkish Journal of Pediatrics

Volumn 47, Issue 2, 2005, Pages 105-110

  Kanra, Güler ^a   Tezcan, Sabahat ^a   Badur, Selim ^b   Alp, Handan ^c   Bulut, Aysen ^d   Cin, Sükrü ^e   Mocan, Gamze ^f   Daǧbaşi, Nükhet ^g   Dündar, Cihat ^h   Egemen, Ayten ⁱ   Eskiocak, Muzaffer ^j   Evliyaog̈lu, Nuran ^k   Güraksin, Aytaç ^c   Kara, Ateş ^a   Mocan, Hilal ^h   Özmert, Elif ^a   Oztürk, Fadil ^f   Saka, Günay ^l   Sidal, Müjgan ^d   Ulukol, Betül ^e   Tanyer, Gülten ^m   Tas, Mehmet Ali ^l   Velicangil, Ömer ^g   Yazicioǧlu, Mehtap ^j   more..

^a HACETTEPE UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ATATURK UNIVERSITY   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

^e ANKARA UNIVERSITY   (Turkey)

^f KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^g GLAXOSMITHKLINE   (United Kingdom)

^h ONDOKUZ MAYIS UNIVERSITY   (Turkey)

ⁱ EGE UNIVERSITY   (Turkey)

^j TRAKYA UNIVERSITY   (Turkey)

^k CUKUROVA UNIVERSITY   (Turkey)

^l DICLE UNIVERSITY   (Turkey)

^m ANKARA NUMUNE HOSPITAL   (Turkey)

more..

Author keywords

Hepatitis B; Measles; Seroprevalence

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; MEASLES VACCINE;

ADOLESCENT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEMAGGLUTINATION INHIBITION TEST; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; POPULATION RESEARCH; SERODIAGNOSIS; SEROPREVALENCE; SEX DIFFERENCE; TURKEY (REPUBLIC); VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; INFANT; MALE; MEASLES; SEROEPIDEMIOLOGIC STUDIES; TURKEY;

EID: 20144371839     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. World Health Organization. Strategic plan for the elimination of measles in the European Region. CMDS 01 01 06/10 Match 3, 1997. Copenhagen. Denmark: WHO Regional Office for Europe.
2. Analysis of the situation of mother and children in Turkey. Turkish State and UNICEF Collaboration Programme 1991-1995. Ankara: Yeniçaǧ Press; 1991.
3. Turkish Demographic and Health Survey 1998. Hacettepe University Institute of Population Studies, MEASURES/DHS+ Macro International Inc., United Nations Population Fund, Ankara, 1998.
4. Kanra G, Tezcan S, Badur S, Turkish National Study Team. Varicella seroprevalence in a random sample of the Turkish population. Vaccine 2002; 20: 1425-1428.
5. Kanra G, Tezcan S, Badur S, Turkish National Study Team. Hepatitis A seroprevalence in Turkey. Turk J Pediatr 2002; 44: 204-210.
6. Hendersen RH, Sunderasan T. Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. Bull WHO 1982; 60: 2053-2060.
7. Epidemiology of hepatitis B infection. Prevention and control of hepatitis B in the community. In Hallauer J (ed). Communicable Disease Series No 1. Geneva: WHO publication; 1996.
8. Turgut H, Kaleli I, Yalçin AN, Çetin ÇB, Çelik A, Akşit F. Investigation of HBsAg positivity in different groups (in Turkish). Viral Hepatit Dergisi (Journal of Viral Hepatitis) 2000; 2: 89-91.
9. Mistik R, Balik I. Epidemiology of viral hepatitis in Turkey: a meta analysis, (in Turkish) In: Kiliçturgay K (ed). Viral Hepatitis'98. İstanbul: Viral Hepatitle Savaşim Derneǧi; 1998: 10-39.
10. Deǧertekin H, Can I. Horizontal spread of hepatitis B infection among school children (in Turkish). Turk J Gastroenterohepatol 1991; 2: 33-36.
11. Tosun SY, Özbakkaloǧlu B, Benzergil S. Hepatitis B seroprevalence in hospital personel (in Turkish). Viral Hepatit Dergisi (Journal of Viral Hepatitis) 1998; 4: 25-27.
12. McMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of carrier state. J Infect Dis 1985; 151: 599-603.
13. Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendation of Immunization Practices Advisory Committee (ACIP). MMWR 1991; 40 (No. RR-13).
14. Crovari P. Epidemiology of viral hepatitis B in Italy. Vaccine 1995; 13 (Suppl): S26-S30.
15. Goudeau A, Dubois F. Incidence and prevalance of hepatitis B in France. Vaccine 1995; 13 (suppl): S22-25.
16. De Melker H, Pebody RG, Edmunds WJ, et al. The seroepidemiology of measles in Western Europe. Epidemiol Infect 2001; 126: 249-259.
17. Krugman S, Katz SL, Gershon AA, Wilfert CM. Infectious Diseases of Children (9th ed). Philadelphia: Mosby Year Book; 1992.
18. Ceyhan M, Kanra G, Erdem G, Kanra B. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age. Vaccine 2001; 19: 4473-4478.